Safe Use of Octreotide During Pregnancy: A Case Report
Author Information
Author(s): Naccache Deeb Daoud, Zaina Adnan, Shen-Or Zila, Armoni Michal, Kontogeorgos George, Yahia Ali
Primary Institution: Rambam Health Campus and Rappaport Faculty of Medicine, Technion, Haifa, Israel
Hypothesis
Can octreotide LAR be safely used during pregnancy without adverse effects on the mother or newborn?
Conclusion
The case supports the safe use of octreotide LAR during pregnancy, resulting in healthy deliveries.
Supporting Evidence
- The patient had three spontaneous pregnancies while on octreotide LAR therapy.
- All three pregnancies resulted in healthy full-term babies.
- The use of octreotide LAR did not lead to any adverse effects on the newborns.
Takeaway
A woman used octreotide during her three pregnancies and had three healthy babies, showing that the treatment can be safe.
Methodology
Case report detailing the patient's medical history and treatment during three pregnancies.
Limitations
The findings are based on a single case report, limiting generalizability.
Participant Demographics
25-year-old Arabic woman with bronchial carcinoid-associated Cushing's syndrome.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website